Vivione Biosciences Inc. (“Vivione” or the “Company”) (TSXV:VBI) today announced the termination of Ted Moskal as President of Vivione and its operating subsidiary, Vivione Biosciences, LLC.
“Ted had a long-standing tenure with Vivione, and we appreciate his contributions,” said Vivione’s Chief Executive Officer, Kevin Kuykendall. “However, as the Company matured and expanded into other markets such as clinical and oil & gas, we began to grow the management team with individuals that were proficient in the areas in which the Company was moving and it became clear that a change needed to be made.”
Help employers find you! Check out all the jobs and post your resume.
